Head-to-Head: which BPH treatment gets men off catheters faster?
NCT ID NCT04338776
Summary
This study compares two minimally invasive treatments for enlarged prostate (BPH): the UroLift System and the Rezūm System. Researchers are tracking 120 men for 12 months to see which treatment helps patients avoid catheters more quickly and reduces the need for additional BPH medications. The study focuses on patient recovery experience and treatment effectiveness over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BENIGN PROSTATIC HYPERPLASIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cambridge University Hospitals NHS Foundation Trust
Cambridge, CB2 0QQ, United Kingdom
-
Comprehensive Urology
Royal Oak, Michigan, 48073, United States
-
Frimley Park Hospital
Frimley, Camberley, 6U167UJ UK, United Kingdom
-
NORFOLK and Norwich University Hospital
Norwich, Norfolk, NR4 7UY, United Kingdom
-
NYU Winthrop Urology
Garden City, New York, 11530, United States
-
Tower Urology
Los Angeles, California, 90048, United States
-
UT Southwestern Medical Center
Dallas, Texas, 75048, United States
-
Urology Austin
Austin, Texas, 78759, United States
-
Urology San Antonio
San Antonio, Texas, 78229, United States
-
Weil Cornell Medical College, Cornell University
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.